1. Home
  2. SUPN vs SKWD Comparison

SUPN vs SKWD Comparison

Compare SUPN & SKWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$47.40

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Skyward Specialty Insurance Group Inc.

SKWD

Skyward Specialty Insurance Group Inc.

HOLD

Current Price

$49.62

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
SKWD
Founded
2005
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.3B
IPO Year
2012
2023

Fundamental Metrics

Financial Performance
Metric
SUPN
SKWD
Price
$47.40
$49.62
Analyst Decision
Strong Buy
Buy
Analyst Count
4
12
Target Price
$63.25
$65.30
AVG Volume (30 Days)
680.6K
358.0K
Earning Date
11-04-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.25
EPS
N/A
3.37
Revenue
$681,539,000.00
$1,335,358,000.00
Revenue This Year
$8.32
$24.41
Revenue Next Year
$23.36
$30.82
P/E Ratio
N/A
$14.73
Revenue Growth
4.54
22.27
52 Week Low
$29.16
$41.28
52 Week High
$57.65
$65.05

Technical Indicators

Market Signals
Indicator
SUPN
SKWD
Relative Strength Index (RSI) 53.89 59.11
Support Level $45.36 $46.30
Resistance Level $47.26 $48.50
Average True Range (ATR) 1.23 1.57
MACD 0.36 0.19
Stochastic Oscillator 95.26 88.98

Price Performance

Historical Comparison
SUPN
SKWD

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About SKWD Skyward Specialty Insurance Group Inc.

Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.

Share on Social Networks: